EORTC Classification for primary cutaneous lymphomas: A comparison with the REAL Classification and the proposed WHO Classification

被引:30
作者
Willemze, R
Meijer, CJLM
机构
[1] Free Univ Amsterdam Hosp, Dept Dermatol, NL-1081 HV Amsterdam, Netherlands
[2] Free Univ Amsterdam Hosp, Dept Pathol, NL-1081 HV Amsterdam, Netherlands
关键词
classification; cutaneous lymphoma; histopathology;
D O I
10.1023/A:1008384631177
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Primary cutaneous lymphomas differ significantly from their nodal equivalents in clinical behaviour and prognosis, and often require a different therapeutic approach. Since currently used classification systems for non-Hodgkin lymphomas do not or insufficiently recognize the special character of these lymphomas, primary cutaneous lymphomas are not uncommonly diagnosed incorrectly, and/or treated inappropriately with unnecessarily aggressive therapies. For that reason the Cutaneous Lymphoma Group of the European Organization for Research and Treatment of Cancer (EORTC) has recently proposed a separate classification For the group of primary cutaneous lymphomas. The EORTC Classification is consistently based on a combination of clinical, histological, immunophenotypical and genetic criteria, and includes well-defined and recognizable disease entities. It contains a limited number of cutaneous T-cell lymphomas and cutaneous B-cell lymphomas. which comprise more than 95% of all primary cutaneous lymphomas. The clinical significance of this classification has been validated by long-term follow-up data of more than 800 patients with a primary cutaneous lymphoma. The basic principles of the EORTC Classification will be presented, and current controversies between the EORTC Classification on the one hand, and the R.E.A.L. Classification and the proposed WHO Classification on the other will be discussed.
引用
收藏
页码:11 / 15
页数:5
相关论文
共 18 条
[1]   Treatment of multifocal primary cutaneous B-cell lymphoma: A clinical follow-up study of 29 patients [J].
Bekkenk, MW ;
Vermeer, MH ;
Geerts, ML ;
Noordijk, EM ;
Heule, F ;
Vader, PCV ;
van Vloten, WA ;
Meijer, CJLM ;
Willemze, R .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (08) :2471-2478
[2]   PRIMARY CUTANEOUS T-CELL LYMPHOMA - CLINICOPATHOLOGICAL FEATURES AND PROGNOSTIC PARAMETERS OF 35 CASES OTHER THAN MYCOSIS-FUNGOIDES AND CD30-POSITIVE LARGE-CELL LYMPHOMA [J].
BELJAARDS, RC ;
MEIJER, CJLM ;
VANDERPUTTE, CJ ;
HOLLEMA, H ;
GEERTS, ML ;
BEZEMER, PD ;
WILLEMZE, R .
JOURNAL OF PATHOLOGY, 1994, 172 (01) :53-60
[3]  
BELJAARDS RC, 1993, CANCER, V71, P2097, DOI 10.1002/1097-0142(19930315)71:6<2097::AID-CNCR2820710626>3.0.CO
[4]  
2-7
[5]   bcl-2 protein expression in primary cutaneous large B-cell lymphoma is site-related [J].
Geelen, FAMJ ;
Vermeer, MH ;
Meijer, CJLM ;
Van der Putte, SCJ ;
Kerkhof, E ;
Kluin, PM ;
Willemze, R .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (06) :2080-2085
[6]  
Grange F, 1999, BLOOD, V93, P3637
[7]  
HARRIS NL, 1994, BLOOD, V84, P1361
[8]  
Jaffe ES, 1999, AM J CLIN PATHOL, V111, pS8
[9]   Classification of cutaneous lymphoma - A critical appraisal of recent proposals [J].
Norton, AJ .
AMERICAN JOURNAL OF DERMATOPATHOLOGY, 1999, 21 (03) :279-287
[10]   Treatment of primary cutaneous B-cell lymphomas of follicle center cell origin: A clinical follow-up study of 55 patients treated with radiotherapy or polychemotherapy [J].
Rijlaarsdam, JU ;
Toonstra, J ;
Meijer, OWM ;
Noordijk, EM ;
Willemze, R .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (02) :549-555